2. INDUSTRY PROFILE
INTRODUCTION:
● India is the world's largest pharmaceutical manufacturer and is
understood for low-priced vaccines and conventional pills.
● Generic drugs, over-the-counter tablets, bulk pills, vaccines,
contract studies and production, biosimilars and biologics are a
number of the primary segments of the Indian pharmaceutical
enterprise.
● India has the largest range of United States Food and Drug
Administration (USFDA) accredited drug manufacturing facilities,
with over 500 API manufacturers accounting for about eight% of
the global API market.
3. MARKET SIZE
● According to the Economic Survey of India 2021, the home market is
expected to triple in the subsequent decade.
● India's home pharmaceutical market became envisioned at US$ forty two
billion in 2021, and is expected to reach US$ sixty five billion by means of
2024 and US$ one hundred twenty-130 billion by 2030.
INVESTMENTS AND RECENT DEVELOPMENTS
● Indian pharmaceutical enterprise plays an crucial function within the
international pharmaceutical enterprise. India ranks 0.33 in production
and 14th in value globally.
● The region has visible numerous investment and growth in latest years.
● India's prescription drugs and pharmaceutical industry received a
cumulative sales of US$ 19.41 billion between April 2000 and March
2012.
4. ● In May 2022, Dr. Reddy's laboratory has entered into an one of a kind
partnership with HK inno.N Corporation to commercialize the brand new
molecule Tegoprazan in India and sure rising markets.
● In April 2022, Dr Reddy's Laboratories Ltd. Signed an agreement with
Medicane Health to announce the launch of medical hashish products in
Germany.
● In November 2021, US company Akston Biosciences announced the begin
of the primary clinical trial of its second-era COVID-19 vaccine in India.
● In August 2021, Glenmark collaborated with SaNOtize to release a bath
for the remedy of COVID-19 in India and other Asian markets.
● In May 2021, Indian Immunologicals Ltd. (IIL) and Bharat Immunological
and Biological Corporation (BIBCOL) have signed a generation switch
agreement with Bharat Biotech to develop a vaccine indigenously for use
in vaccination campaigns in India. Both PSUs plan to begin production the
vaccine from September 2021.
5. COMPANY PROFILE
● Dr. Reddy's Laboratories Limited became installed in 1984 by means of Dr. K.
Anji Reddy grew to turn out to be India's third biggest pharmaceutical
agency.
● Reddy manufactures and markets a extensive variety of pharmaceutical
merchandise in India and abroad.
● Dr. Reddy believes in growing an environment wherein the conduct and
behavioral parameters of the enterprise and its management are constantly
aligned with the business surroundings.
● By 2012, Reddy had six FDA-permitted pharmaceutical manufacturing
centers in India, seven FDA-inspected and ISO 9001 (Quality) and ISO 16001
(Environmental Management) certified. Established patient-prepared drug
manufacturing facilities – 5 of them in India and two in the UK
● By 2016, Dr. Reddy's Q3 FY10 sales become Rs. 18,401 million, EBITDA of
Rs. 3,453 million, PAT Rs. 1,924 million
6. VISION & MISSIONS
● In 1984, Dr. Reddy's Laboratories (NYSE: RDY ) is a growing
global pharmaceutical corporation with confirmed studies
abilities.
● It manufactures finished dosage forms, energetic
pharmaceutical components and biotechnological products
and markets them globally with recognition on India, USA,
Europe and Russia.
● The agency conducts studies in the regions of diabetes,
cardiovascular sickness, anti-contamination, inflammation
and cancer.
7. AWARDS
2021 CMO Leadership Awards - Congratulations To Dr. Reddy's Laboratories
● Source: Outsourced Pharma
● On behalf of all of us at Outsourced Pharma and Life Science Leadership, we
congratulate the 2021 winners of the Outstanding CMO Leadership Award.
● Luis Carquillo, creator of The Pharma Outsourced Manager, shares a special
message with them.
● Successful organizations and their personnel, whose tough work and
determination help them get excessive marks from their customers.
Best Supply Chain Team of the Year - Pharma- 2021
January 21,2021
● We are thrilled to announce that our group received the Best Supply Chain
Team Award at the twenty eighth Inflection Pharma SC & Gold Chain e-
Expo & Awards on January 21, 2021.
8. FINANCIAL GROWTH :
● DRREDDY announced its consolidated financial
outcomes for the area ended June 30, 2018, in
accordance with International Financial Reporting
Standards (IFRS).
● NUE: RS.Three,721 Crore
● Gross Margin: fifty five.7%
● R&D Expenditure: RS 121 Cr
● Earnings before tax: RS DI cr
● Post Office Earning: RS456 Crore
9. BOARD OF DIRECTORS
KEY PERSONS
1. Mr. Dr. K. Anji Reddy - Govt
2. MGV Prasad - Vice President & CEO
3.M. Satish Reddy - MD & COO
4. OmkarGauswami.
5.Dr Ravi Boothalingam
6.Mr Krishna Palebu
7.Mr KalpanaMorbaria
8. M. JP Further
10. DATA ANALYSIS AND INTERPRETATION
Is the physical working conditions are taken care by the
superiors?
Response No of Respondents % of Respondents
Very poor 0 0
Poor 0 0
Moderate 12 20
Good 42 70
Excellent 6 10
Total 60 100
11. According to you what are the basic essential
features to motive?
Options
No.
Respondents
%
Respon
dents
Promotions 38 38
Rewards 50 50
Training in abroad 12 12
Total 100 100 100 100
12. Do you agree that personality development is the
essential character of motivation to
improve yourself towards performance of your job
Options
No.
Respondent
s
%
Respondents
Yes 70 70
No 30 30
Total 100 100
13. How do employees feel being in Dr.Reddy's?
Options Total No. Respondents % Respondents Total
Feel safe and secure 75 75 75
Feel loyal 10 10 20
Feel valued 5 5 5
14. Recognition to good work
Response
No of
Respondents
% of
Respondents
not at all 2 3.3
rare 22 36.7
sometimes 32 53.3
many a times 4 6.7
always 0 0
Total 60 100
15. Response of superiors when employees
approach them with difficulties at work.
Response No of Respondents % of Respondents
ignorant 2 3.3
serious and angry 4 6.7
warm and friendly 54 90
Total 60 100
18. FINDINGS
● The look at indicates that the working situations within the corporation are
accurate however they want schooling and are unassailable.
● Organizational culture is excellent with exquisite superior subordinate
members of the family.
SUGGESTIONS
● Appraisal ought to be a form of suitable performance management in order that
proper performers are rewarded and much less a success are promoted. It
increases the morale of the personnel.
● Good work is continually recognized. Therefore management need to broaden
techniques to recognize incredible personnel. That is the honesty of the worker.
19. CONCLUSION
● Based on the evaluation of the questionnaires of the
employees of Dr.Reddy's Ltd. From the Hyderabad records,
entitled ―Employee Motivation and Morale‖, motivating
elements for personnel aren't outside factors like earnings,
however many. They are intrinsic, that is, employees are
encouraged with the aid of the work tradition in their
company.